Navigation Links
Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Topamax(R) Tablets
Date:4/2/2009

DETROIT, April 2 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE AMEX: CPD) has launched Topiramate tablets on behalf of Sun Pharmaceutical Industries Ltd. (Sun Pharma), immediately following Sun Pharma's recently received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for generic Topamax(R) tablets.

Topiramate tablets are used as initial monotherapy in patients 10 years of age and older with partial onset seizures, or primary generalized tonic-clonic seizures. Topiramate tablets are indicated as adjunctive therapy for adults and pediatric patients ages 2-16 years with partial onset seizures, or primary generalized tonic-clonic seizures, and in patients 2 years of age and older with seizures associated with Lennox-Gastaut syndrome. These generic versions of Topamax 25 mg, 50 mg, 100 mg, and 200 mg tablets are bioequivalent to Topamax(R) which is a registered trademark of Ortho McNeil Janssen Pharmaceuticals, Inc. According to IMS Data, these strengths of Topiramate had US sales of approximately $2.3 billion for the calendar year of 2008.

Daniel H. Movens, Caraco's Chief Executive Officer, said, "We are pleased to add this product to our portfolio by launching Topiramate tablets immediately to the marketplace. We continue to focus on working towards expanding our product offering both as a marketing partner and through our own development pipeline of products as quickly and effectively as possible."

Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures, markets and distributes generic and private-label pharmaceuticals to the nation's largest wholesalers, distributors, drugstore chains and managed care providers.

Safe Harbor: This news release contains forward-looking statements made pursuant to
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces a Nationwide Voluntary Recall of All Lots of Digoxin Tablets Due to Size Variability
2. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009
3. Caraco Pharmaceutical Laboratories, Ltd. to Announce Third Quarter of Fiscal Year 2009 Results on January 29, 2009
4. Caraco Pharmaceutical Laboratories, Ltd. Responds to FDA Warning Letter
5. Caraco Pharmaceutical Laboratories, Ltd. Update on FDA Warning Letter
6. Caraco Pharmaceutical Laboratories, Ltd. to Market Generic Sinemet(R) Tablets
7. Caraco Pharmaceutical Laboratories, Ltd. Reaches Agreement with Labor Union
8. Caraco Pharmaceutical Laboratories, Ltd. to Market Generic Depakote(R) Delayed Release Tablets
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Elavil(R)
10. Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008
11. Caraco Pharmaceutical Laboratories, Ltd. to Announce Fourth Quarter and Fiscal Year 2008 Results on May 29, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015 CompanionDx announced that ... genomic analysis in personalized cancer therapy: Non-small cell lung ... Society of Clinical Oncology (ASCO) as part of their ... , The molecular and clinical data used for the ... database. The study reports improved patient outcomes from a ...
(Date:5/27/2015)... On June 5, Plan B [the ... with LifeSource to host Donate Your Break, a public ... a LifeSource donor coach outside of 116 W. Illinois ... Demand for whole blood units is highest for LifeSource, ... months. LifeSource requires approximately 1,000 donations per day to ...
(Date:5/27/2015)... This is a professional and ... Omega-3 industry. The report provides a basic overview ... industry chain structure. The Omega-3 market analysis is ... competitive landscape analysis, and key regions development status. ... Company, Seadragon Marine Oils, Norwegian Fish Oil, Croda ...
(Date:5/27/2015)... Meadows, IL (PRWEB) May 27, 2015 ... release of its SonarMD Platform, a first-of-its ... monitoring and managing patients with chronic gastrointestinal ... Kosinski, MD, MBA, the application allows physicians ... visits through the ongoing use of electronic ...
(Date:5/27/2015)... “Heroin has never been more plentiful or ... coming from,” says Harford County Sheriff Jeff Gahler, as quoted ... the surging heroin related incidents in Baltimore, police resources are ... prevent heroin addiction and subsequent abuse before it turns into ... Baltimore is a drug and alcohol rehab facility specializing in ...
Breaking Medicine News(10 mins):Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 2Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 3Health News:Donate Your Break and Save Lives at the River North Blood Drive 2Health News:Omega-3 Market: Global 2015 Analysis & 2020 Forecasts on Market Size 2Health News:SonarMD™, LLC, Launches Game-Changing, IBD Population Health Management Platform 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 3
... Service Provider Chooses SonicWALL to Satisfy Business Need ... SonicWALL, Inc. (Nasdaq: SNWL ... announced that ZirMed, Inc., a leader in revenue ... Louisville, Kentucky, has implemented a SonicWALL(R) E-Class NSA ...
... Clarient, Inc. (Nasdaq: CLRT ... resource for pathologists, oncologists and the pharmaceutical industry, today ... renewed, expanded and extended its senior subordinated revolving credit ... SFE ), Clarient,s majority shareholder."In the current market ...
... medical equipment supplier, now sells its DRE Integra AV-S with a ventilator ... patients attempt to breathe spontaneously. , ... (Vocus) March 3, 2009 -- ... by Business First of Louisville, continues expanding its DRE Integra AV-S ...
... releases the first in a series of residential vacuum cleaner reviews ... , ... Boise, Idaho (Vocus) March 3, 2009 -- Before spending hundreds of ... the market, savvy shoppers turn to the Internet to research their choices. ...
... incidence of obesity-induced type 2 diabetes mellitus continues to ... obesity can completely eliminate all manifestations of diabetes. In ... The American Journal of Medicine , investigators analyzed ... showed that 78.1% of diabetic patients had complete resolution ...
... that helps trigger autoimmunity could lead to new treatments ... kill thousands of children annually, according to researchers. , ... has discovered genetic evidence that two distinct molecular ... a vitally important cell type in limiting undesirable immune ...
Cached Medicine News:Health News:SonicWALL Delivers Flexible High-Performance Threat Management for ZirMed 2Health News:SonicWALL Delivers Flexible High-Performance Threat Management for ZirMed 3Health News:Clarient Renews and Expands Mezzanine Credit Facility With Safeguard 2Health News:Clarient Renews and Expands Mezzanine Credit Facility With Safeguard 3Health News:Clarient Renews and Expands Mezzanine Credit Facility With Safeguard 4Health News:DRE AV-S Ventilator Now Has Multiple Spontaneous Breathing Modes 2Health News:DRE AV-S Ventilator Now Has Multiple Spontaneous Breathing Modes 3Health News:DRE AV-S Ventilator Now Has Multiple Spontaneous Breathing Modes 4Health News:Shopping for a Vacuum Cleaner? Know What You're Buying! Internet Site and Rating System Can Help 2Health News:Shopping for a Vacuum Cleaner? Know What You're Buying! Internet Site and Rating System Can Help 3Health News:Study shows potential for resolving type 2 diabetes with bariatric surgery 2Health News:Genetic evidence points to potential therapeutic bypass for autoimmune process 2Health News:Genetic evidence points to potential therapeutic bypass for autoimmune process 3
(Date:5/27/2015)... 2015 E-QURE, Corp. (OTCQB: EQUR), ... the development and commercialization of its Bio-electrical Signal Therapy ... the noninvasive treatment of hard to heal chronic wounds, ... Cap Research http://scr.zacks.com issued a quarterly update ... Zacks, research update, E-QURE Corp "…has a compelling story ...
(Date:5/27/2015)... -- Medical Device Contract Manufacturing - new ... Where is the market for medical ... prospects for this market and medical device ... shows you potential revenues and other trends to 2025, ... page report provides 127 tables, charts, and graphs. Discover ...
(Date:5/27/2015)... CITY , May 27, 2015  Foundation Health ... surgeries and related ancillary services, announced today it will ... held June 1-3, 2015 at Luxe Sunset Boulevard Hotel, ... be presenting on Tuesday, June 2 nd at ... To schedule a one-on-one meeting please contact LD Micro. ...
Breaking Medicine Technology:Zacks Investment Small Cap Research Issues Quarterly Update on E-QURE 2Zacks Investment Small Cap Research Issues Quarterly Update on E-QURE 3Medical Device Contract Manufacturing Market Forecast 2015-2025 2Medical Device Contract Manufacturing Market Forecast 2015-2025 3Medical Device Contract Manufacturing Market Forecast 2015-2025 4Medical Device Contract Manufacturing Market Forecast 2015-2025 5Medical Device Contract Manufacturing Market Forecast 2015-2025 6Medical Device Contract Manufacturing Market Forecast 2015-2025 7
... Landauer, Inc. (NYSE: LDR) announced today that ... of $0.55 per share for the second quarter of fiscal ... shareholders of record on March 9, 2012. ... technical and analytical services to determine occupational and environmental radiation ...
... 2012  In an effort to maximize business impact and ... research leaders must constantly evaluate the manner in which ... understand the optimal balance of external contract employees in ... quickly changing healthcare industry. To identify innovative ...
Cached Medicine Technology:Current Study Offers Window into Automation & Outsourcing Practices Within Top Pharmaceutical Market Research Groups 2
... Ruschelit® PVC. 2 eyes, oral. ... patient age. X-ray opaque line. Graduated. ... access. Designed to reduce kinking of ... curvature. Thermosensitive Ruschelit® PVC adapts to ...
... PVC. 2 eyes, oral. Marked with ... X-ray opaque line. Graduated. Single use. ... reduce kinking of the tube by ... adapts to the anatomical situation at ...
... Slick Set® Tube with stylet inside. ... quality cuffed Rusch endotracheal tube with ... to use saving you time and ... coded for easy identification and has ...
Ruschelit® PVC. Murphy eye-nasoral. Black positioning ring. High volume/low pressure cuff. X-ray opaque line. Graduated. Single use....
Medicine Products: